These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28169058)

  • 1. Accuracy of computer-calculated and manual QRS duration assessments: Clinical implications to select candidates for cardiac resynchronization therapy.
    De Pooter J; El Haddad M; Stroobandt R; De Buyzere M; Timmermans F
    Int J Cardiol; 2017 Jun; 236():276-282. PubMed ID: 28169058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Underestimation of duration of ventricular activation by 12-lead ECG compared with direct measurement of activation duration derived from implanted pacemaker leads.
    Duncan AM; Lim E; Mebrate Y; Wong T; Gibson DG
    Int J Cardiol; 2011 Oct; 152(1):35-42. PubMed ID: 20678820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential response to cardiac resynchronization therapy and clinical outcomes according to QRS morphology and QRS duration.
    Dupont M; Rickard J; Baranowski B; Varma N; Dresing T; Gabi A; Finucan M; Mullens W; Wilkoff BL; Tang WH
    J Am Coll Cardiol; 2012 Aug; 60(7):592-8. PubMed ID: 22796255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of QRS Morphology and Duration on Clinical Outcomes After Cardiac Resynchronization Therapy　- Analysis of Japanese Multicenter Registry.
    Oka T; Inoue K; Tanaka K; Hirao Y; Isshiki T; Kimura T; Nobuyoshi M; Shizuta S; Arita T; Fujii S; Iwakura K; Fujii K; Ando K
    Circ J; 2018 Jun; 82(7):1813-1821. PubMed ID: 29628460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reproducibility of measuring QRS duration and implications for optimization of interventricular pacing delay in cardiac resynchronization therapy.
    Stephansen C; Kronborg MB; Witt CT; Kristensen J; Gerdes C; Sommer A; Jensen JM; Nielsen JC
    Ann Noninvasive Electrocardiol; 2019 May; 24(3):e12621. PubMed ID: 30521128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QRS frequency characteristics help predict response to cardiac resynchronization in left bundle branch block less than 150 milliseconds.
    Niebauer MJ; Rickard J; Polakof L; Tchou PJ; Varma N
    Heart Rhythm; 2014 Dec; 11(12):2183-9. PubMed ID: 25068573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probability and magnitude of response to cardiac resynchronization therapy according to QRS duration and gender in nonischemic cardiomyopathy and LBBB.
    Varma N; Manne M; Nguyen D; He J; Niebauer M; Tchou P
    Heart Rhythm; 2014 Jul; 11(7):1139-47. PubMed ID: 24704570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of manual QRS duration assessment: its importance in patient selection for cardiac resynchronization and implantable cardioverter defibrillator therapy.
    Tomlinson DR; Bashir Y; Betts TR; Rajappan K
    Europace; 2009 May; 11(5):638-42. PubMed ID: 19174376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of PR interval prolongation on long-term outcomes in patients with left bundle branch block vs non-left bundle branch block morphologies undergoing cardiac resynchronization therapy.
    Rickard J; Karim M; Baranowski B; Cantillon D; Spragg D; Tang WHW; Niebauer M; Grimm R; Trulock K; Wilkoff B; Varma N
    Heart Rhythm; 2017 Oct; 14(10):1523-1528. PubMed ID: 28549996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implantable Cardioverter-Defibrillators With Versus Without Resynchronization Therapy in Patients With a QRS Duration >180 ms.
    Sundaram V; Sahadevan J; Waldo AL; Stukenborg GJ; Reddy YNV; Asirvatham SJ; Mackall JA; Intini A; Wilson B; Simon DI; Bilchick KC
    J Am Coll Cardiol; 2017 Apr; 69(16):2026-2036. PubMed ID: 28427578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precision and reproducibility of non-automatic measurement of the QRS complex in potential candidates for cardiac resynchronization therapy.
    Caro-Codón J; Rey JR; Díaz Cruz J; Martínez Marín LA; García de Veas Marquéz JM; Castrejón S; Martínez Cossiani M; Rodríguez Sotelo L; López-Sendón JL; Merino JL
    J Electrocardiol; 2019; 57():90-94. PubMed ID: 31574350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different Methods to Measure QRS Duration in CRT Patients: Impact on the Predictive Value of QRS Duration Parameters.
    De Pooter J; El Haddad M; Timmers L; Van Heuverswyn F; Jordaens L; Duytschaever M; Stroobandt R
    Ann Noninvasive Electrocardiol; 2016 May; 21(3):305-15. PubMed ID: 26391903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender differences in electro-mechanical characteristics of left bundle branch block: Potential implications for selection and response of cardiac resynchronization therapy.
    De Pooter J; Kamoen V; El Haddad M; Stroobandt R; De Buyzere M; Jordaens L; Timmermans F
    Int J Cardiol; 2018 Apr; 257():84-91. PubMed ID: 29506744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precision of automated QRS duration measurement in patients treated with cardiac resynchronization therapy.
    Lund-Andersen C; Petersen HH; Jøns C; Philbert BT; Tfelt-Hansen J; Skovgaard LT; Svendsen JH
    J Interv Card Electrophysiol; 2018 Jun; 52(1):103-110. PubMed ID: 29508111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ventricular geometry-regularized QRSd predicts cardiac resynchronization therapy response: machine learning from crosstalk between electrocardiography and echocardiography.
    Lei J; Wang YG; Bhatta L; Ahmed J; Fan D; Wang J; Liu K
    Int J Cardiovasc Imaging; 2019 Jul; 35(7):1221-1229. PubMed ID: 31104177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Narrower QRS may be enough to respond to cardiac resynchronization therapy in lightweight patients.
    Nakai T; Mano H; Ikeya Y; Aizawa Y; Kurokawa S; Ohkubo K; Nagashima K; Watanabe I; Okumura Y
    Heart Vessels; 2020 Jun; 35(6):835-841. PubMed ID: 31776736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between QRS duration and resynchronization window for CRT optimization: Implications for CRT in narrow QRS patients.
    Harbin MM; Brown CD; Espinoza EA; Burns KV; Bank AJ
    J Electrocardiol; 2022; 72():72-78. PubMed ID: 35344747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of QRS morphology and duration on outcomes after cardiac resynchronization therapy: Results from the Resynchronization-Defibrillation for Ambulatory Heart Failure Trial (RAFT).
    Birnie DH; Ha A; Higginson L; Sidhu K; Green M; Philippon F; Thibault B; Wells G; Tang A
    Circ Heart Fail; 2013 Nov; 6(6):1190-8. PubMed ID: 23995437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjusting the QRS Duration by Body Mass Index for Prediction of Response to Cardiac Resynchronization Therapy: Does One QRS Size Fit All?
    Karaca O; Omaygenc MO; Cakal B; Cakal SD; Gunes HM; Olgun E; Ibisoglu E; Savur U; Gokdeniz T; Boztosun B; Kilicaslan F
    Ann Noninvasive Electrocardiol; 2016 Sep; 21(5):450-9. PubMed ID: 26820486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left Ventricular Size does not Modify the Effect of QRS Duration in Predicting Response to Cardiac Resynchronization Therapy.
    Rickard J; Baranowski B; Grimm RA; Niebauer M; Varma N; Tang WHW; Wilkoff BL
    Pacing Clin Electrophysiol; 2017 May; 40(5):482-487. PubMed ID: 28164328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.